Matthew B. Murphy, General Counsel at Nautilus Biotechnology, Inc. (NAUT), bought 10,000 shares at $2.85 ($28K) on 2022-08-12, disclosed to the SEC on 2022-08-16.
Open-market purchase of $28k NAUT by General Counsel. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.85 | 2,500 | $7K | 25.1% |
| 2 | $2.84 | 7,500 | $21K | 74.9% |
| Total | $2.84 avg | 10,000 | $28K | 100% |
| Filing → |